Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1609304

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1609304

Global Gadoterate Meglumine Market Insights, Forecast to 2030

PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Gadoterate Meglumine Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Gadoterate Meglumine Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Gadoterate Meglumine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
    • 1.2.2 1.8845Gm/5Ml
    • 1.2.3 3.769Gm/10Ml
    • 1.2.4 5.6535Gm/15Ml
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Gadoterate Meglumine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Gadoterate Meglumine Revenue Estimates and Forecasts 2019-2030
  • 2.2 Global Gadoterate Meglumine Revenue by Region
    • 2.2.1 Global Gadoterate Meglumine Revenue by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Global Gadoterate Meglumine Revenue by Region (2019-2024)
    • 2.2.3 Global Gadoterate Meglumine Revenue by Region (2025-2030)
    • 2.2.4 Global Gadoterate Meglumine Revenue Market Share by Region (2019-2030)
  • 2.3 Global Gadoterate Meglumine Sales Estimates and Forecasts 2019-2030
  • 2.4 Global Gadoterate Meglumine Sales by Region
    • 2.4.1 Global Gadoterate Meglumine Sales by Region: 2019 VS 2023 VS 2030
    • 2.4.2 Global Gadoterate Meglumine Sales by Region (2019-2024)
    • 2.4.3 Global Gadoterate Meglumine Sales by Region (2025-2030)
    • 2.4.4 Global Gadoterate Meglumine Sales Market Share by Region (2019-2030)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

  • 3.1 Global Gadoterate Meglumine Sales by Manufacturers
    • 3.1.1 Global Gadoterate Meglumine Sales by Manufacturers (2019-2024)
    • 3.1.2 Global Gadoterate Meglumine Sales Market Share by Manufacturers (2019-2024)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gadoterate Meglumine in 2023
  • 3.2 Global Gadoterate Meglumine Revenue by Manufacturers
    • 3.2.1 Global Gadoterate Meglumine Revenue by Manufacturers (2019-2024)
    • 3.2.2 Global Gadoterate Meglumine Revenue Market Share by Manufacturers (2019-2024)
    • 3.2.3 Global Top 10 and Top 5 Companies by Gadoterate Meglumine Revenue in 2023
  • 3.3 Global Key Players of Gadoterate Meglumine, Industry Ranking, 2021 VS 2022
  • 3.4 Global Gadoterate Meglumine Sales Price by Manufacturers (2019-2024)
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Gadoterate Meglumine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Gadoterate Meglumine, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Gadoterate Meglumine, Product Offered and Application
  • 3.8 Global Key Manufacturers of Gadoterate Meglumine, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Gadoterate Meglumine Sales by Type
    • 4.1.1 Global Gadoterate Meglumine Historical Sales by Type (2019-2024)
    • 4.1.2 Global Gadoterate Meglumine Forecasted Sales by Type (2025-2030)
    • 4.1.3 Global Gadoterate Meglumine Sales Market Share by Type (2019-2030)
  • 4.2 Global Gadoterate Meglumine Revenue by Type
    • 4.2.1 Global Gadoterate Meglumine Historical Revenue by Type (2019-2024)
    • 4.2.2 Global Gadoterate Meglumine Forecasted Revenue by Type (2025-2030)
    • 4.2.3 Global Gadoterate Meglumine Revenue Market Share by Type (2019-2030)
  • 4.3 Global Gadoterate Meglumine Price by Type
    • 4.3.1 Global Gadoterate Meglumine Price by Type (2019-2024)
    • 4.3.2 Global Gadoterate Meglumine Price Forecast by Type (2025-2030)

5 Market Size by Application

  • 5.1 Global Gadoterate Meglumine Sales by Application
    • 5.1.1 Global Gadoterate Meglumine Historical Sales by Application (2019-2024)
    • 5.1.2 Global Gadoterate Meglumine Forecasted Sales by Application (2025-2030)
    • 5.1.3 Global Gadoterate Meglumine Sales Market Share by Application (2019-2030)
  • 5.2 Global Gadoterate Meglumine Revenue by Application
    • 5.2.1 Global Gadoterate Meglumine Historical Revenue by Application (2019-2024)
    • 5.2.2 Global Gadoterate Meglumine Forecasted Revenue by Application (2025-2030)
    • 5.2.3 Global Gadoterate Meglumine Revenue Market Share by Application (2019-2030)
  • 5.3 Global Gadoterate Meglumine Price by Application
    • 5.3.1 Global Gadoterate Meglumine Price by Application (2019-2024)
    • 5.3.2 Global Gadoterate Meglumine Price Forecast by Application (2025-2030)

6 US & Canada

  • 6.1 US & Canada Gadoterate Meglumine Market Size by Type
    • 6.1.1 US & Canada Gadoterate Meglumine Sales by Type (2019-2030)
    • 6.1.2 US & Canada Gadoterate Meglumine Revenue by Type (2019-2030)
  • 6.2 US & Canada Gadoterate Meglumine Market Size by Application
    • 6.2.1 US & Canada Gadoterate Meglumine Sales by Application (2019-2030)
    • 6.2.2 US & Canada Gadoterate Meglumine Revenue by Application (2019-2030)
  • 6.3 US & Canada Gadoterate Meglumine Market Size by Country
    • 6.3.1 US & Canada Gadoterate Meglumine Revenue by Country: 2019 VS 2023 VS 2030
    • 6.3.2 US & Canada Gadoterate Meglumine Revenue by Country (2019-2030)
    • 6.3.3 US & Canada Gadoterate Meglumine Sales by Country (2019-2030)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Gadoterate Meglumine Market Size by Type
    • 7.1.1 Europe Gadoterate Meglumine Sales by Type (2019-2030)
    • 7.1.2 Europe Gadoterate Meglumine Revenue by Type (2019-2030)
  • 7.2 Europe Gadoterate Meglumine Market Size by Application
    • 7.2.1 Europe Gadoterate Meglumine Sales by Application (2019-2030)
    • 7.2.2 Europe Gadoterate Meglumine Revenue by Application (2019-2030)
  • 7.3 Europe Gadoterate Meglumine Market Size by Country
    • 7.3.1 Europe Gadoterate Meglumine Revenue by Country: 2019 VS 2023 VS 2030
    • 7.3.2 Europe Gadoterate Meglumine Revenue by Country (2019-2030)
    • 7.3.3 Europe Gadoterate Meglumine Sales by Country (2019-2030)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Gadoterate Meglumine Market Size by Type
    • 8.1.1 China Gadoterate Meglumine Sales by Type (2019-2030)
    • 8.1.2 China Gadoterate Meglumine Revenue by Type (2019-2030)
  • 8.2 China Gadoterate Meglumine Market Size by Application
    • 8.2.1 China Gadoterate Meglumine Sales by Application (2019-2030)
    • 8.2.2 China Gadoterate Meglumine Revenue by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Gadoterate Meglumine Market Size by Type
    • 9.1.1 Asia Gadoterate Meglumine Sales by Type (2019-2030)
    • 9.1.2 Asia Gadoterate Meglumine Revenue by Type (2019-2030)
  • 9.2 Asia Gadoterate Meglumine Market Size by Application
    • 9.2.1 Asia Gadoterate Meglumine Sales by Application (2019-2030)
    • 9.2.2 Asia Gadoterate Meglumine Revenue by Application (2019-2030)
  • 9.3 Asia Gadoterate Meglumine Market Size by Region
    • 9.3.1 Asia Gadoterate Meglumine Revenue by Region: 2019 VS 2023 VS 2030
    • 9.3.2 Asia Gadoterate Meglumine Revenue by Region (2019-2030)
    • 9.3.3 Asia Gadoterate Meglumine Sales by Region (2019-2030)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India
    • 9.3.9 Australia

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Gadoterate Meglumine Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Gadoterate Meglumine Sales by Type (2019-2030)
    • 10.1.2 Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Type (2019-2030)
  • 10.2 Middle East, Africa and Latin America Gadoterate Meglumine Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Gadoterate Meglumine Sales by Application (2019-2030)
    • 10.2.2 Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Application (2019-2030)
  • 10.3 Middle East, Africa and Latin America Gadoterate Meglumine Market Size by Country
    • 10.3.1 Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Country: 2019 VS 2023 VS 2030
    • 10.3.2 Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Country (2019-2030)
    • 10.3.3 Middle East, Africa and Latin America Gadoterate Meglumine Sales by Country (2019-2030)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Corporate Profile

  • 11.1 Guerbet Group
    • 11.1.1 Guerbet Group Company Information
    • 11.1.2 Guerbet Group Overview
    • 11.1.3 Guerbet Group Gadoterate Meglumine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.1.4 Guerbet Group Gadoterate Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Guerbet Group Recent Developments
  • 11.2 Hengrui Medicine
    • 11.2.1 Hengrui Medicine Company Information
    • 11.2.2 Hengrui Medicine Overview
    • 11.2.3 Hengrui Medicine Gadoterate Meglumine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.2.4 Hengrui Medicine Gadoterate Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Hengrui Medicine Recent Developments
  • 11.3 GE Healthcare
    • 11.3.1 GE Healthcare Company Information
    • 11.3.2 GE Healthcare Overview
    • 11.3.3 GE Healthcare Gadoterate Meglumine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.3.4 GE Healthcare Gadoterate Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 GE Healthcare Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Gadoterate Meglumine Industry Chain Analysis
  • 12.2 Gadoterate Meglumine Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Gadoterate Meglumine Production Mode & Process
  • 12.4 Gadoterate Meglumine Sales and Marketing
    • 12.4.1 Gadoterate Meglumine Sales Channels
    • 12.4.2 Gadoterate Meglumine Distributors
  • 12.5 Gadoterate Meglumine Customers

13 Gadoterate Meglumine Market Dynamics

  • 13.1 Gadoterate Meglumine Industry Trends
  • 13.2 Gadoterate Meglumine Market Drivers
  • 13.3 Gadoterate Meglumine Market Challenges
  • 13.4 Gadoterate Meglumine Market Restraints

14 Key Findings in the Global Gadoterate Meglumine Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 15.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Author Details
  • 15.3 Disclaimer

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Gadoterate Meglumine Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Gadoterate Meglumine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
    • 1.2.2 1.8845Gm/5Ml
    • 1.2.3 3.769Gm/10Ml
    • 1.2.4 5.6535Gm/15Ml
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Gadoterate Meglumine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Gadoterate Meglumine Revenue Estimates and Forecasts 2019-2030
  • 2.2 Global Gadoterate Meglumine Revenue by Region
    • 2.2.1 Global Gadoterate Meglumine Revenue by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Global Gadoterate Meglumine Revenue by Region (2019-2024)
    • 2.2.3 Global Gadoterate Meglumine Revenue by Region (2025-2030)
    • 2.2.4 Global Gadoterate Meglumine Revenue Market Share by Region (2019-2030)
  • 2.3 Global Gadoterate Meglumine Sales Estimates and Forecasts 2019-2030
  • 2.4 Global Gadoterate Meglumine Sales by Region
    • 2.4.1 Global Gadoterate Meglumine Sales by Region: 2019 VS 2023 VS 2030
    • 2.4.2 Global Gadoterate Meglumine Sales by Region (2019-2024)
    • 2.4.3 Global Gadoterate Meglumine Sales by Region (2025-2030)
    • 2.4.4 Global Gadoterate Meglumine Sales Market Share by Region (2019-2030)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

  • 3.1 Global Gadoterate Meglumine Sales by Manufacturers
    • 3.1.1 Global Gadoterate Meglumine Sales by Manufacturers (2019-2024)
    • 3.1.2 Global Gadoterate Meglumine Sales Market Share by Manufacturers (2019-2024)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gadoterate Meglumine in 2023
  • 3.2 Global Gadoterate Meglumine Revenue by Manufacturers
    • 3.2.1 Global Gadoterate Meglumine Revenue by Manufacturers (2019-2024)
    • 3.2.2 Global Gadoterate Meglumine Revenue Market Share by Manufacturers (2019-2024)
    • 3.2.3 Global Top 10 and Top 5 Companies by Gadoterate Meglumine Revenue in 2023
  • 3.3 Global Key Players of Gadoterate Meglumine, Industry Ranking, 2021 VS 2022
  • 3.4 Global Gadoterate Meglumine Sales Price by Manufacturers (2019-2024)
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Gadoterate Meglumine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Gadoterate Meglumine, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Gadoterate Meglumine, Product Offered and Application
  • 3.8 Global Key Manufacturers of Gadoterate Meglumine, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Gadoterate Meglumine Sales by Type
    • 4.1.1 Global Gadoterate Meglumine Historical Sales by Type (2019-2024)
    • 4.1.2 Global Gadoterate Meglumine Forecasted Sales by Type (2025-2030)
    • 4.1.3 Global Gadoterate Meglumine Sales Market Share by Type (2019-2030)
  • 4.2 Global Gadoterate Meglumine Revenue by Type
    • 4.2.1 Global Gadoterate Meglumine Historical Revenue by Type (2019-2024)
    • 4.2.2 Global Gadoterate Meglumine Forecasted Revenue by Type (2025-2030)
    • 4.2.3 Global Gadoterate Meglumine Revenue Market Share by Type (2019-2030)
  • 4.3 Global Gadoterate Meglumine Price by Type
    • 4.3.1 Global Gadoterate Meglumine Price by Type (2019-2024)
    • 4.3.2 Global Gadoterate Meglumine Price Forecast by Type (2025-2030)

5 Market Size by Application

  • 5.1 Global Gadoterate Meglumine Sales by Application
    • 5.1.1 Global Gadoterate Meglumine Historical Sales by Application (2019-2024)
    • 5.1.2 Global Gadoterate Meglumine Forecasted Sales by Application (2025-2030)
    • 5.1.3 Global Gadoterate Meglumine Sales Market Share by Application (2019-2030)
  • 5.2 Global Gadoterate Meglumine Revenue by Application
    • 5.2.1 Global Gadoterate Meglumine Historical Revenue by Application (2019-2024)
    • 5.2.2 Global Gadoterate Meglumine Forecasted Revenue by Application (2025-2030)
    • 5.2.3 Global Gadoterate Meglumine Revenue Market Share by Application (2019-2030)
  • 5.3 Global Gadoterate Meglumine Price by Application
    • 5.3.1 Global Gadoterate Meglumine Price by Application (2019-2024)
    • 5.3.2 Global Gadoterate Meglumine Price Forecast by Application (2025-2030)

6 US & Canada

  • 6.1 US & Canada Gadoterate Meglumine Market Size by Type
    • 6.1.1 US & Canada Gadoterate Meglumine Sales by Type (2019-2030)
    • 6.1.2 US & Canada Gadoterate Meglumine Revenue by Type (2019-2030)
  • 6.2 US & Canada Gadoterate Meglumine Market Size by Application
    • 6.2.1 US & Canada Gadoterate Meglumine Sales by Application (2019-2030)
    • 6.2.2 US & Canada Gadoterate Meglumine Revenue by Application (2019-2030)
  • 6.3 US & Canada Gadoterate Meglumine Market Size by Country
    • 6.3.1 US & Canada Gadoterate Meglumine Revenue by Country: 2019 VS 2023 VS 2030
    • 6.3.2 US & Canada Gadoterate Meglumine Revenue by Country (2019-2030)
    • 6.3.3 US & Canada Gadoterate Meglumine Sales by Country (2019-2030)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Gadoterate Meglumine Market Size by Type
    • 7.1.1 Europe Gadoterate Meglumine Sales by Type (2019-2030)
    • 7.1.2 Europe Gadoterate Meglumine Revenue by Type (2019-2030)
  • 7.2 Europe Gadoterate Meglumine Market Size by Application
    • 7.2.1 Europe Gadoterate Meglumine Sales by Application (2019-2030)
    • 7.2.2 Europe Gadoterate Meglumine Revenue by Application (2019-2030)
  • 7.3 Europe Gadoterate Meglumine Market Size by Country
    • 7.3.1 Europe Gadoterate Meglumine Revenue by Country: 2019 VS 2023 VS 2030
    • 7.3.2 Europe Gadoterate Meglumine Revenue by Country (2019-2030)
    • 7.3.3 Europe Gadoterate Meglumine Sales by Country (2019-2030)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Gadoterate Meglumine Market Size by Type
    • 8.1.1 China Gadoterate Meglumine Sales by Type (2019-2030)
    • 8.1.2 China Gadoterate Meglumine Revenue by Type (2019-2030)
  • 8.2 China Gadoterate Meglumine Market Size by Application
    • 8.2.1 China Gadoterate Meglumine Sales by Application (2019-2030)
    • 8.2.2 China Gadoterate Meglumine Revenue by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Gadoterate Meglumine Market Size by Type
    • 9.1.1 Asia Gadoterate Meglumine Sales by Type (2019-2030)
    • 9.1.2 Asia Gadoterate Meglumine Revenue by Type (2019-2030)
  • 9.2 Asia Gadoterate Meglumine Market Size by Application
    • 9.2.1 Asia Gadoterate Meglumine Sales by Application (2019-2030)
    • 9.2.2 Asia Gadoterate Meglumine Revenue by Application (2019-2030)
  • 9.3 Asia Gadoterate Meglumine Market Size by Region
    • 9.3.1 Asia Gadoterate Meglumine Revenue by Region: 2019 VS 2023 VS 2030
    • 9.3.2 Asia Gadoterate Meglumine Revenue by Region (2019-2030)
    • 9.3.3 Asia Gadoterate Meglumine Sales by Region (2019-2030)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India
    • 9.3.9 Australia

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Gadoterate Meglumine Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Gadoterate Meglumine Sales by Type (2019-2030)
    • 10.1.2 Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Type (2019-2030)
  • 10.2 Middle East, Africa and Latin America Gadoterate Meglumine Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Gadoterate Meglumine Sales by Application (2019-2030)
    • 10.2.2 Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Application (2019-2030)
  • 10.3 Middle East, Africa and Latin America Gadoterate Meglumine Market Size by Country
    • 10.3.1 Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Country: 2019 VS 2023 VS 2030
    • 10.3.2 Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Country (2019-2030)
    • 10.3.3 Middle East, Africa and Latin America Gadoterate Meglumine Sales by Country (2019-2030)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Corporate Profile

  • 11.1 Guerbet Group
    • 11.1.1 Guerbet Group Company Information
    • 11.1.2 Guerbet Group Overview
    • 11.1.3 Guerbet Group Gadoterate Meglumine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.1.4 Guerbet Group Gadoterate Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Guerbet Group Recent Developments
  • 11.2 Hengrui Medicine
    • 11.2.1 Hengrui Medicine Company Information
    • 11.2.2 Hengrui Medicine Overview
    • 11.2.3 Hengrui Medicine Gadoterate Meglumine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.2.4 Hengrui Medicine Gadoterate Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Hengrui Medicine Recent Developments
  • 11.3 GE Healthcare
    • 11.3.1 GE Healthcare Company Information
    • 11.3.2 GE Healthcare Overview
    • 11.3.3 GE Healthcare Gadoterate Meglumine Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.3.4 GE Healthcare Gadoterate Meglumine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 GE Healthcare Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Gadoterate Meglumine Industry Chain Analysis
  • 12.2 Gadoterate Meglumine Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Gadoterate Meglumine Production Mode & Process
  • 12.4 Gadoterate Meglumine Sales and Marketing
    • 12.4.1 Gadoterate Meglumine Sales Channels
    • 12.4.2 Gadoterate Meglumine Distributors
  • 12.5 Gadoterate Meglumine Customers

13 Gadoterate Meglumine Market Dynamics

  • 13.1 Gadoterate Meglumine Industry Trends
  • 13.2 Gadoterate Meglumine Market Drivers
  • 13.3 Gadoterate Meglumine Market Challenges
  • 13.4 Gadoterate Meglumine Market Restraints

14 Key Findings in the Global Gadoterate Meglumine Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 15.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Author Details
  • 15.3 Disclaimer

List of Tables

Table 1. Global Gadoterate Meglumine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of 1.8845Gm/5Ml

Table 3. Major Manufacturers of 3.769Gm/10Ml

Table 4. Major Manufacturers of 5.6535Gm/15Ml

Table 5. Major Manufacturers of Others

Table 6. Global Gadoterate Meglumine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Gadoterate Meglumine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Gadoterate Meglumine Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Gadoterate Meglumine Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Gadoterate Meglumine Revenue Market Share by Region (2019-2024)

Table 11. Global Gadoterate Meglumine Revenue Market Share by Region (2025-2030)

Table 12. Global Gadoterate Meglumine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K L)

Table 13. Global Gadoterate Meglumine Sales by Region (2019-2024) & (K L)

Table 14. Global Gadoterate Meglumine Sales by Region (2025-2030) & (K L)

Table 15. Global Gadoterate Meglumine Sales Market Share by Region (2019-2024)

Table 16. Global Gadoterate Meglumine Sales Market Share by Region (2025-2030)

Table 17. Global Gadoterate Meglumine Sales by Manufacturers (2019-2024) & (K L)

Table 18. Global Gadoterate Meglumine Sales Share by Manufacturers (2019-2024)

Table 19. Global Gadoterate Meglumine Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Gadoterate Meglumine Revenue Market Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Gadoterate Meglumine, Industry Ranking, 2021 VS 2022 VS 2023

Table 22. Gadoterate Meglumine Price by Manufacturers (2019-2024) & (US$/L)

Table 23. Global Gadoterate Meglumine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Gadoterate Meglumine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gadoterate Meglumine as of 2023)

Table 25. Global Key Manufacturers of Gadoterate Meglumine, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Gadoterate Meglumine, Product Offered and Application

Table 27. Global Key Manufacturers of Gadoterate Meglumine, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Gadoterate Meglumine Sales by Type (2019-2024) & (K L)

Table 30. Global Gadoterate Meglumine Sales by Type (2025-2030) & (K L)

Table 31. Global Gadoterate Meglumine Sales Share by Type (2019-2024)

Table 32. Global Gadoterate Meglumine Sales Share by Type (2025-2030)

Table 33. Global Gadoterate Meglumine Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Gadoterate Meglumine Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Gadoterate Meglumine Revenue Share by Type (2019-2024)

Table 36. Global Gadoterate Meglumine Revenue Share by Type (2025-2030)

Table 37. Gadoterate Meglumine Price by Type (2019-2024) & (US$/L)

Table 38. Global Gadoterate Meglumine Price Forecast by Type (2025-2030) & (US$/L)

Table 39. Global Gadoterate Meglumine Sales by Application (2019-2024) & (K L)

Table 40. Global Gadoterate Meglumine Sales by Application (2025-2030) & (K L)

Table 41. Global Gadoterate Meglumine Sales Share by Application (2019-2024)

Table 42. Global Gadoterate Meglumine Sales Share by Application (2025-2030)

Table 43. Global Gadoterate Meglumine Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Gadoterate Meglumine Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Gadoterate Meglumine Revenue Share by Application (2019-2024)

Table 46. Global Gadoterate Meglumine Revenue Share by Application (2025-2030)

Table 47. Gadoterate Meglumine Price by Application (2019-2024) & (US$/L)

Table 48. Global Gadoterate Meglumine Price Forecast by Application (2025-2030) & (US$/L)

Table 49. US & Canada Gadoterate Meglumine Sales by Type (2019-2024) & (K L)

Table 50. US & Canada Gadoterate Meglumine Sales by Type (2025-2030) & (K L)

Table 51. US & Canada Gadoterate Meglumine Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Gadoterate Meglumine Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Gadoterate Meglumine Sales by Application (2019-2024) & (K L)

Table 54. US & Canada Gadoterate Meglumine Sales by Application (2025-2030) & (K L)

Table 55. US & Canada Gadoterate Meglumine Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Gadoterate Meglumine Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Gadoterate Meglumine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Gadoterate Meglumine Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Gadoterate Meglumine Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Gadoterate Meglumine Sales by Country (2019-2024) & (K L)

Table 61. US & Canada Gadoterate Meglumine Sales by Country (2025-2030) & (K L)

Table 62. Europe Gadoterate Meglumine Sales by Type (2019-2024) & (K L)

Table 63. Europe Gadoterate Meglumine Sales by Type (2025-2030) & (K L)

Table 64. Europe Gadoterate Meglumine Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Gadoterate Meglumine Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Gadoterate Meglumine Sales by Application (2019-2024) & (K L)

Table 67. Europe Gadoterate Meglumine Sales by Application (2025-2030) & (K L)

Table 68. Europe Gadoterate Meglumine Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Gadoterate Meglumine Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Gadoterate Meglumine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Gadoterate Meglumine Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Gadoterate Meglumine Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Gadoterate Meglumine Sales by Country (2019-2024) & (K L)

Table 74. Europe Gadoterate Meglumine Sales by Country (2025-2030) & (K L)

Table 75. China Gadoterate Meglumine Sales by Type (2019-2024) & (K L)

Table 76. China Gadoterate Meglumine Sales by Type (2025-2030) & (K L)

Table 77. China Gadoterate Meglumine Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Gadoterate Meglumine Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Gadoterate Meglumine Sales by Application (2019-2024) & (K L)

Table 80. China Gadoterate Meglumine Sales by Application (2025-2030) & (K L)

Table 81. China Gadoterate Meglumine Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Gadoterate Meglumine Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Gadoterate Meglumine Sales by Type (2019-2024) & (K L)

Table 84. Asia Gadoterate Meglumine Sales by Type (2025-2030) & (K L)

Table 85. Asia Gadoterate Meglumine Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Gadoterate Meglumine Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Gadoterate Meglumine Sales by Application (2019-2024) & (K L)

Table 88. Asia Gadoterate Meglumine Sales by Application (2025-2030) & (K L)

Table 89. Asia Gadoterate Meglumine Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Gadoterate Meglumine Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Gadoterate Meglumine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Gadoterate Meglumine Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Gadoterate Meglumine Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Gadoterate Meglumine Sales by Region (2019-2024) & (K L)

Table 95. Asia Gadoterate Meglumine Sales by Region (2025-2030) & (K L)

Table 96. Middle East, Africa and Latin America Gadoterate Meglumine Sales by Type (2019-2024) & (K L)

Table 97. Middle East, Africa and Latin America Gadoterate Meglumine Sales by Type (2025-2030) & (K L)

Table 98. Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Gadoterate Meglumine Sales by Application (2019-2024) & (K L)

Table 101. Middle East, Africa and Latin America Gadoterate Meglumine Sales by Application (2025-2030) & (K L)

Table 102. Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Gadoterate Meglumine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Gadoterate Meglumine Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Gadoterate Meglumine Sales by Country (2019-2024) & (K L)

Table 108. Middle East, Africa and Latin America Gadoterate Meglumine Sales by Country (2025-2030) & (K L)

Table 109. Guerbet Group Company Information

Table 110. Guerbet Group Description and Major Businesses

Table 111. Guerbet Group Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)

Table 112. Guerbet Group Gadoterate Meglumine Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Guerbet Group Recent Developments

Table 114. Hengrui Medicine Company Information

Table 115. Hengrui Medicine Description and Major Businesses

Table 116. Hengrui Medicine Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)

Table 117. Hengrui Medicine Gadoterate Meglumine Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Hengrui Medicine Recent Developments

Table 119. GE Healthcare Company Information

Table 120. GE Healthcare Description and Major Businesses

Table 121. GE Healthcare Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)

Table 122. GE Healthcare Gadoterate Meglumine Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. GE Healthcare Recent Developments

Table 124. Key Raw Materials Lists

Table 125. Raw Materials Key Suppliers Lists

Table 126. Gadoterate Meglumine Distributors List

Table 127. Gadoterate Meglumine Customers List

Table 128. Gadoterate Meglumine Market Trends

Table 129. Gadoterate Meglumine Market Drivers

Table 130. Gadoterate Meglumine Market Challenges

Table 131. Gadoterate Meglumine Market Restraints

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

List of Figures

Figure 1. Gadoterate Meglumine Product Picture

Figure 2. Global Gadoterate Meglumine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Gadoterate Meglumine Market Share by Type: 2023 & 2030

Figure 4. 1.8845Gm/5Ml Product Picture

Figure 5. 3.769Gm/10Ml Product Picture

Figure 6. 5.6535Gm/15Ml Product Picture

Figure 7. Others Product Picture

Figure 8. Global Gadoterate Meglumine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Gadoterate Meglumine Market Share by Application: 2023 & 2030

Figure 10. Hospitals

Figure 11. Clinics

Figure 12. Gadoterate Meglumine Report Years Considered

Figure 13. Global Gadoterate Meglumine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 15. Global Gadoterate Meglumine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 16. Global Gadoterate Meglumine Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 17. Global Gadoterate Meglumine Revenue Market Share by Region (2019-2030)

Figure 18. Global Gadoterate Meglumine Sales (2019-2030) & (K L)

Figure 19. Global Gadoterate Meglumine Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K L)

Figure 20. Global Gadoterate Meglumine Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Gadoterate Meglumine Sales YoY (2019-2030) & (K L)

Figure 22. US & Canada Gadoterate Meglumine Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Gadoterate Meglumine Sales YoY (2019-2030) & (K L)

Figure 24. Europe Gadoterate Meglumine Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Gadoterate Meglumine Sales YoY (2019-2030) & (K L)

Figure 26. China Gadoterate Meglumine Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Gadoterate Meglumine Sales YoY (2019-2030) & (K L)

Figure 28. Asia (excluding China) Gadoterate Meglumine Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Gadoterate Meglumine Sales YoY (2019-2030) & (K L)

Figure 30. Middle East, Africa and Latin America Gadoterate Meglumine Revenue YoY (2019-2030) & (US$ Million)

Figure 31. Global Gadoterate Meglumine Sales Share by Manufacturers (2023)

Figure 32. The Gadoterate Meglumine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 33. Global Gadoterate Meglumine Revenue Share by Manufacturers (2023)

Figure 34. The Top 5 and 10 Largest Manufacturers of Gadoterate Meglumine in the World: Market Share by Gadoterate Meglumine Revenue in 2023

Figure 35. Global Gadoterate Meglumine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 36. Global Gadoterate Meglumine Sales Market Share by Type (2019-2030)

Figure 37. Global Gadoterate Meglumine Revenue Market Share by Type (2019-2030)

Figure 38. Global Gadoterate Meglumine Sales Market Share by Application (2019-2030)

Figure 39. Global Gadoterate Meglumine Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Gadoterate Meglumine Sales Market Share by Type (2019-2030)

Figure 41. US & Canada Gadoterate Meglumine Revenue Market Share by Type (2019-2030)

Figure 42. US & Canada Gadoterate Meglumine Sales Market Share by Application (2019-2030)

Figure 43. US & Canada Gadoterate Meglumine Revenue Market Share by Application (2019-2030)

Figure 44. US & Canada Gadoterate Meglumine Revenue Share by Country (2019-2030)

Figure 45. US & Canada Gadoterate Meglumine Sales Share by Country (2019-2030)

Figure 46. US Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 47. Canada Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 48. Europe Gadoterate Meglumine Sales Market Share by Type (2019-2030)

Figure 49. Europe Gadoterate Meglumine Revenue Market Share by Type (2019-2030)

Figure 50. Europe Gadoterate Meglumine Sales Market Share by Application (2019-2030)

Figure 51. Europe Gadoterate Meglumine Revenue Market Share by Application (2019-2030)

Figure 52. Europe Gadoterate Meglumine Revenue Share by Country (2019-2030)

Figure 53. Europe Gadoterate Meglumine Sales Share by Country (2019-2030)

Figure 54. Germany Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 55. France Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 56. U.K. Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 57. Italy Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 58. Russia Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 59. China Gadoterate Meglumine Sales Market Share by Type (2019-2030)

Figure 60. China Gadoterate Meglumine Revenue Market Share by Type (2019-2030)

Figure 61. China Gadoterate Meglumine Sales Market Share by Application (2019-2030)

Figure 62. China Gadoterate Meglumine Revenue Market Share by Application (2019-2030)

Figure 63. Asia Gadoterate Meglumine Sales Market Share by Type (2019-2030)

Figure 64. Asia Gadoterate Meglumine Revenue Market Share by Type (2019-2030)

Figure 65. Asia Gadoterate Meglumine Sales Market Share by Application (2019-2030)

Figure 66. Asia Gadoterate Meglumine Revenue Market Share by Application (2019-2030)

Figure 67. Asia Gadoterate Meglumine Revenue Share by Region (2019-2030)

Figure 68. Asia Gadoterate Meglumine Sales Share by Region (2019-2030)

Figure 69. Japan Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 70. South Korea Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 71. China Taiwan Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 72. Southeast Asia Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 73. India Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 74. Australia Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 75. Middle East, Africa and Latin America Gadoterate Meglumine Sales Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Gadoterate Meglumine Revenue Market Share by Type (2019-2030)

Figure 77. Middle East, Africa and Latin America Gadoterate Meglumine Sales Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Gadoterate Meglumine Revenue Market Share by Application (2019-2030)

Figure 79. Middle East, Africa and Latin America Gadoterate Meglumine Revenue Share by Country (2019-2030)

Figure 80. Middle East, Africa and Latin America Gadoterate Meglumine Sales Share by Country (2019-2030)

Figure 81. Brazil Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 82. Mexico Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 83. Turkey Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 84. Israel Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 85. GCC Countries Gadoterate Meglumine Revenue (2019-2030) & (US$ Million)

Figure 86. Gadoterate Meglumine Value Chain

Figure 87. Gadoterate Meglumine Production Process

Figure 88. Channels of Distribution (Direct Vs Distribution)

Figure 89. Bottom-up and Top-down Approaches for This Report

Figure 90. Data Triangulation

Figure 91. Key Executives Interviewed

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!